Mélanie Serrero
About
Mélanie Serrero is a scholar working on Genetics, Epidemiology and Surgery.
According to data from OpenAlex, Mélanie Serrero has authored 32 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Genetics, 20 papers in Epidemiology and 17 papers in Surgery. Recurrent topics in Mélanie Serrero's work include Inflammatory Bowel Disease (25 papers), Microscopic Colitis (15 papers) and Immunodeficiency and Autoimmune Disorders (6 papers). Mélanie Serrero is often cited by papers focused on Inflammatory Bowel Disease (25 papers), Microscopic Colitis (15 papers) and Immunodeficiency and Autoimmune Disorders (6 papers). Mélanie Serrero collaborates with scholars based in France, Belgium and Norway. Mélanie Serrero's co-authors include Fanny Grimaud, Jean–Charles Grimaud, C. Philandrianos, Laurent Peyrin‐Biroulet, Ariadne Desjeux, Maria Nachury, Lucine Vuitton, Florence Sabatier, Mathurin Fuméry and Aurélien Amiot and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Virology.
In The Last Decade
Mélanie Serrero
29 papers receiving 293 citations
Peers
Mélanie Serrero
Sarah Caspersen Denmark
Takahiro Beppu Japan
Gert A. Van Assche Belgium
Ottaviano Tarantino Italy
Eric Maller United States
Édouard Chabrun France
Maria Weidinger Germany
T. Andus Germany
Satoshi Motoya Japan
Sara N. Horst United States
Citations per year, relative to Mélanie Serrero Mélanie Serrero (= 1×)
peers
Sarah Caspersen
Countries citing papers authored by Mélanie Serrero
Since
Specialization
Citations
This map shows the geographic impact of Mélanie Serrero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mélanie Serrero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mélanie Serrero more than expected).
Fields of papers citing papers by Mélanie Serrero
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Mélanie Serrero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mélanie Serrero. The network helps show where Mélanie Serrero may publish in the future.
Co-authorship network of co-authors of Mélanie Serrero
This figure shows the co-authorship network connecting the top 25 collaborators of Mélanie Serrero. A scholar is included among the top collaborators of Mélanie Serrero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mélanie Serrero. Mélanie Serrero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Buisson, Anthony, Maria Nachury, Mathieu Uzzan, et al.. (2025). P0611 Effectiveness comparisons between tofacitinib, filgotinib and upadacitinib in ulcerative colitis: results from the JAKARTA real-world evidence multicenter study. Journal of Crohn s and Colitis. 19(Supplement_1). i1211–i1211.
2.
Buisson, Anthony, Laurent Peyrin‐Biroulet, Gilles Boschetti, et al.. (2025). P0649 Acceptability and Tolerance of Risankizumab Treatment Administered via On-Body Injector in Patients with Crohn’s Disease: Results of the Nationwide ACCEPT-OBI Study. Journal of Crohn s and Colitis. 19(Supplement_1). i1274–i1274.
3.
Guillo, Lucas, Mélanie Velier, Mélanie Serrero, et al.. (2025). Efficacy of mesenchymal stem cell-based therapies in the treatment of perianal fistulizing Crohn’s disease: a systematic review and meta-analysis. Stem Cell Research & Therapy. 16(1). 152–152.
4.
Fuméry, Mathurin, Mélanie Serrero, Guillaume Bouguen, et al.. (2024). Real-World Comparison of the Effectiveness between Ustekinumab and Vedolizumab in Patients with Ulcerative Colitis Exposed to at least One Anti-TNF Agent. Journal of Crohn s and Colitis. 18(10). 1615–1621.
5.
Nancey, Stéphane, Mélanie Serrero, Ludovic Caillo, et al.. (2023). Risk of infection in elderly patients with inflammatory bowel disease under biologics: A prospective, multicenter, observational, one-year follow-up comparative study. Clinics and Research in Hepatology and Gastroenterology. 47(5). 102107–102107.
6.
Buisson, Anthony, Mélanie Serrero, Romain Altwegg, et al.. (2023). P579 Real-world comparison of effectiveness between tofacitinib and ustekinumab in patients with ulcerative colitis exposed to at least one anti-TNF agent: results from the TORUS study. Journal of Crohn s and Colitis. 17(Supplement_1). i707–i707.
7.
Amiot, Aurélien, Delphine Gaye, Nora Frulio, et al.. (2023). Preoperative Predictors of Neoplasia in Patients Undergoing Small Bowel Resection for Complicated Crohn’s Disease: A Multicentre Case-Control Study. Cancers. 15(7). 2004–2004.
8.
Buisson, Anthony, Maria Nachury, Romain Altwegg, et al.. (2022). Real‐world comparison of effectiveness between tofacitinib and vedolizumab in patients with ulcerative colitis exposed to at least one anti‐TNF agent. Alimentary Pharmacology & Therapeutics. 57(6). 676–688.
9.
Guillo, Lucas, Fanny Grimaud, Élisabeth Jouve, et al.. (2022). Three-year outcome of local injection of autologous stromal vascular fraction cells and microfat in refractory perianal fistulas of Crohn’s disease. Stem Cell Research & Therapy. 13(1). 67–67.
10.
Poullenot, Florian, Aurélien Amiot, Maria Nachury, et al.. (2022). Comparative Risk of Incident Cancer in Patients with Inflammatory Bowel Disease with Prior Non-digestive Malignancy According to Immunomodulator: a Multicentre Cohort Study. Journal of Crohn s and Colitis. 16(10). 1523–1530.
11.
Serrero, Mélanie, Ludovic Caillo, Cyrielle Gilletta, et al.. (2022). P604 Infection Risk in Elderly Patients with Inflammatory Bowel Disease under anti-TNF, ustekinumab or vedolizumab biologic therapies: A Prospective Multicenter observational One-Year follow-up comparative study. Journal of Crohn s and Colitis. 16(Supplement_1). i537–i537.
12.
Uzzan, Mathieu, David Laharie, Carmen Stefănescu, et al.. (2021). Tofacitinib as salvage therapy for 55 patients hospitalised with refractory severe ulcerative colitis: A GETAID cohort. Alimentary Pharmacology & Therapeutics. 54(3). 312–319.
13.
Bourrier, Anne, Maria Nachury, Stéphane Nancey, et al.. (2020). Vedolizumab for perianal Crohn’s disease: a multicentre cohort study in 151 patients. Alimentary Pharmacology & Therapeutics. 51(7). 719–727.
14.
Guillo, Lucas, Ferdinando D’Amico, Mélanie Serrero, et al.. (2020). Assessment of extraintestinal manifestations in inflammatory bowel diseases: A systematic review and a proposed guide for clinical trials. United European Gastroenterology Journal. 8(9). 1013–1030.
15.
Serrero, Mélanie, et al.. (2019). Long-term Safety and Efficacy of Local Microinjection Combining Autologous Microfat and Adipose-Derived Stromal Vascular Fraction for the Treatment of Refractory Perianal Fistula in Crohn’s Disease. Gastroenterology. 156(8). 2335–2337.e2.
16.
Biron, Christine A., Philippe Seksik, Maria Nachury, et al.. (2019). DOP78 Efficacy of vedolizumab in perianal Crohn’s disease: the BioLAP multi-centre observational study. Journal of Crohn s and Colitis. 13(Supplement_1). S077–S077.
17.
Bertin, Daniel, Mélanie Serrero, Jean Charles Grimaud, Ariadne Desjeux, & Sophie Desplat‐Jégo. (2019). Monitoring of infliximab trough levels and anti-infliximab antibodies in inflammatory bowel diseases: A comparison of three commercially available ELISA kits. Cytokine. 126. 154859–154859.
18.
Philandrianos, C., Mélanie Serrero, Fanny Grimaud, et al.. (2018). First clinical case report of local microinjection of autologous fat and adipose-derived stromal vascular fraction for perianal fistula in Crohn’s disease. Stem Cell Research & Therapy. 9(1). 4–4.
19.
Serrero, Mélanie, C. Philandrianos, Julie Véran, et al.. (2017). OP008 An innovative treatment for refractory perianal fistulas in Crohn's disease: local micro reinjection of autologous fat and adipose derived stromal vascular fraction. Journal of Crohn s and Colitis. 11(suppl_1). S5–S5.
20.
Colson, Philippe, Patrick Borentain, Diane Coso, et al.. (2015). Hepatitis B virus reactivation in HBsAg-negative patients is associated with emergence of viral strains with mutated HBsAg and reverse transcriptase. Virology. 484. 354–363.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Sarah Caspersen Breakdown of academic impact, for papers by Takahiro Beppu Breakdown of academic impact, for papers by Gert A. Van Assche Breakdown of academic impact, for papers by Ottaviano Tarantino Breakdown of academic impact, for papers by Eric Maller Breakdown of academic impact, for papers by Édouard Chabrun Breakdown of academic impact, for papers by Maria Weidinger Breakdown of academic impact, for papers by T. Andus Breakdown of academic impact, for papers by Satoshi Motoya Breakdown of academic impact, for papers by Sara N. Horst